At a glance
Q: Does intracrine vitamin D activity show in blood levels?
A: Not directly. Intracrine signalling occurs inside cells and may not match circulating measurements.
Q: Is intracrine activity the same everywhere in the body?
A: No. It varies with tissue type, enzymes, receptors, and metabolic environment.
Q: Is intracrine signalling the main way vitamin D works?
A: It is one important mechanism alongside endocrine and paracrine routes.
Read the full article below ↓How Vitamin D Acts Inside the Same Cell Where It Is Activated
Intracrine activity refers to signalling that happens entirely inside a single cell. In this form of regulation, a cell activates a signalling molecule and then responds to it internally, without releasing it to act on nearby cells or distant tissues. Vitamin D is capable of intracrine activity, providing a way for cells to fine-tune their own internal behaviour.
In vitamin D biology, intracrine action means a cell can convert vitamin D precursors into the active form inside itself and then respond to that active form directly. This adds another layer of control beyond circulating hormones or kidney-based activation and links closely with how vitamin D is activated inside tissues.
Some tissues activate vitamin D locally without changing blood levels. This helps explain why measured values in the bloodstream do not always reflect what vitamin D is doing inside specific cells or organs, a theme also discussed in tissue-specific vitamin D effects that differ from blood tests.
Intracrine signalling compared with other signalling types
Cells use several communication styles. Endocrine signalling works through hormones released into the bloodstream. Paracrine signalling involves messages passed to neighbouring cells. Autocrine signalling refers to a cell releasing a substance that then acts back on itself from outside. Intracrine signalling is different again because activation and response occur completely inside the same cell.
This adds refinement to broader regulatory systems described in vitamin D signalling pathways across the body and whole-system vitamin D regulation.
Local activation inside the cell
Certain cells possess the full enzymatic machinery required to:
• convert precursors into active vitamin D
• bind this active form to internal receptors
• trigger downstream responses
This means important vitamin D activity can occur within cells independently of kidney activation or circulating hormone levels.
Such local activity is an example of where vitamin D acts at cellular and tissue level.
Vitamin D receptors and internal responses
Once activated, vitamin D binds to receptors located inside cells. These include receptors in:
• the nucleus
• the cytoplasm
• mitochondria
Through these receptors, vitamin D influences gene expression, mitochondrial behaviour, stress responses, and cellular metabolism. These mechanisms rely on vitamin D receptors and their cellular locations.
Why intracrine vitamin D activity matters
Intracrine vitamin D signalling allows cells to:
• respond rapidly to local change
• regulate their own survival and differentiation
• adapt metabolism to demand
• integrate nutrient and endocrine signals
This is particularly important in immune and barrier tissues where rapid responses are required. It forms part of vitamin D’s role in systemic regulation and adaptability.
Interaction with nutrients and the wider physiological context
Intracrine vitamin D activity does not occur in isolation. It interacts with nutrient networks, endocrine processes, and cellular stress responses. Co-nutrients such as magnesium influence the enzymes that activate vitamin D, and this sits within how vitamin D operates within nutrient networks and how magnesium supports vitamin D activity.
Individual variation
Intracrine vitamin D activity differs between individuals because of:
• genetics
• enzyme expression
• receptor density
• life stage
• metabolic health
This explains why vitamin D responses vary, even when blood results appear similar, connecting with why vitamin D differences occur between people.
Differences Between Blood Levels and Cellular Activity
Intracrine vitamin D activity helps explain why blood measurements do not always match how vitamin D is functioning inside tissues. A person may have a similar circulating level to someone else while showing different cellular behaviour because local activation, receptor density and intracellular enzyme availability differ. Intracrine signalling therefore contributes to variation in biological response without necessarily altering standard test results. This distinction is important when considering why symptoms, outcomes or physiological markers sometimes differ despite apparently similar vitamin D status.
Intracrine Vitamin D and Physiological Adaptation
Intracrine activity also plays a role in adaptation to changing conditions. Cells exposed to different workloads, metabolic demands or immune challenges may alter their own internal vitamin D activation as part of their adjustment process. This allows tissues to fine-tune functions such as repair, immune readiness, energy metabolism and barrier integrity according to local needs. Intracrine signalling therefore supports a flexible, adaptive biological system rather than a single fixed response driven only by whole-body vitamin D levels.
Why Intracrine Activity Changes Individual Responses
Because intracrine signalling is cell-specific, two people with identical intake and identical sunlight exposure may still not respond in the same way. Genetic differences in enzymes and receptors, differences in inflammation, variation in magnesium status, illness, ageing and hormonal state can all alter intracrine activity. This helps explain why vitamin D biology often shows individual variation and why a one-number target for everyone is unlikely to capture genuine physiological complexity. Intracrine activity is one of the reasons vitamin D needs to be considered within whole-system biology rather than as an isolated nutrient acting the same way in every person.
A physiology-first perspective
Intracrine signalling reinforces the value of understanding vitamin D through biological mechanisms, not only numbers. A physiology-first perspective considers activation, transport, tissue use, and cellular regulation together. This aligns directly with a physiology-first framework for vitamin.
Key takeaways
Vitamin D can be activated and used inside the same cell
Intracrine signalling does not necessarily show in blood tests
Local activation explains differences between individuals
It interacts with receptors, mitochondria and gene expression
It supports a physiology-first understanding of vitamin D
External links
NIH Office of Dietary Supplements: Vitamin D Fact Sheet
NCBI: Vitamin D physiology overview
MedlinePlus: Vitamin D
Related reading
Intracrine Vitamin D Activity and Cell-Specific Physiology: Full Study
How local vitamin D activation affects cells and tissues, what four core studies show, and where animal evidence and intracellular-action claims remain limited.
Read more →Intracrine Vitamin D Activity and Cell-Specific Physiology: Study Summary
A plain-English summary of local vitamin D activity in cells and tissues, including animal findings, their limits and what they do not establish for patients.
Read more →Vitamin D and Paracrine Signalling
Explore how vitamin D operates through paracrine signalling, enabling local, tissue-specific regulation within broader physiological systems.
Read more →Intracrine conversion and local control of vitamin D metabolism: Study Summary
A concise study summary of intracrine vitamin D metabolism, local calcitriol production, CYP27B1 activity and tissue-specific control mechanisms.
Read more →Intracrine conversion and local control of vitamin D metabolism: Full Evidence Review
A full evidence review of intracrine vitamin D metabolism, examining local calcitriol production, CYP27B1 regulation and tissue-specific control.
Read more →Vitamin D3 as an Input Signal in Endocrine and Intracrine Systems: Full Evidence Review
Research-grade analysis of a verified primary study examining vitamin D3 as an endocrine and intracrine input signal, with strict evidence boundaries and separation of physiological context.
Read more →Vitamin D3 as an Input Signal in Endocrine and Intracrine Systems: Study Summary
Concise summary of a verified scientific study on vitamin D3 as an endocrine and intracrine signalling input, with clear interpretation boundaries and a link to the full evidence review.
Read more →Clinical and molecular correlation defines activity of physiological pathways in life-sustaining kidney xenotransplantation
Porcine kidney xenotransplantation is accelerating towards clinical translation.
Original paper ↗Read more →CYP24A1 Exacerbated Activity during Diabetes Contributes to Kidney Tubular Apoptosis via Caspase-3 Increased Expression and Activation
Decreases in circulating 25,hydroxyl-vitamin D3 (25 OH D3) and 1,25,dihydroxyl-vitamin D3 (1,25 (OH)2 D3) have been extensively documented in patients with type 2 diabetes.
Original paper ↗Read more →Effects of Decreased Vitamin D and Accumulated Uremic Toxin on Human CYP3A4 Activity in Patients with End-Stage Renal Disease
The purpose of this study is to elucidate the reason for the decrease in hepatic clearance in patients with end-stage renal disease.
Original paper ↗Read more →Genomic actions of 1,25-dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats
The candidate VDREs identified may respond to 1,25D3 via activation of the vitamin D receptor, although this remains to be investigated.
Original paper ↗Read more →Physical Activity and Health-Related Quality of Life in Kidney Transplant Recipients: A Cross-Sectional Exploratory Study of Clinical and Inflammatory Parameters
The aim was to evaluate PA levels in KTRs and explore their associations with HRQoL, clinical characteristics, and biochemical and inflammatory markers.
Original paper ↗Read more →Regular Physical Activity in the Prevention of Post-Transplant Diabetes Mellitus in Patients after Kidney Transplantation
Background and Objectives: Post-transplant diabetes mellitus (PTDM) is a significant risk factor for the survival of graft recipients and occurs in 10 to 30% of patients after kidney transplant (KT).
Original paper ↗Read more →Serum 25(OH)D levels are associated with disease activity and renal involvement in initial-onset childhood systemic lupus erythematosus
Compared with the controls (25.53 ± 7.02 ng/ml), patients with initial-onset SLE during childhood have lower serum 25(OH)D levels (18.63 ± 5.32 ng/ml) (P.
Original paper ↗Read more →Bone Turnover in Patients with Chronic Kidney Disease Stage 5D and Healthy Controls: a Quantitative [18F]Fluoride PET Study
We compared optimized quantitative [18F]fluoride PET/CT methods to the reference standard with arterial input function (AIF) to identify a clinically accessible method for evaluation of bone turnover in patients with CKD.
Original paper ↗Read more →Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study
The objective of this study is to evaluate the effect of oral sodium bicarbonate on circulating FGF23 levels in patients with CKD.
Original paper ↗Read more →Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients
Serum calcium, phosphate, alkaline phosphatase,parathyroid hormone, FGF-23, 25(OH)D, 1,25(OH)2D and Fractional excretion of phosphorous were assessed and compared between the two groups, using SPSS software.
Original paper ↗Read more →Outcomes of bisphosphonate and its supplements for bone loss in kidney transplant recipients: a systematic review and network meta-analysis
As there is no consensus on the optimal treatment for post-kidney transplant recipients (KTRs), we aimed to evaluate the efficacy and safety of bisphosphonate and its combined therapies.
Original paper ↗Read more →The impact of a needs-oriented dental prophylaxis program on bacteremia after toothbrushing and systemic inflammation in children, adolescents, and young adults with chronic kidney disease
General prevalence of bacteremia after toothbrushing was 9.5% affecting 7 (26%) of the participants.
Original paper ↗Read more →Vitamin D and osteoporosis in chronic kidney disease
Osteoporotic fractures are common in patients with chronic kidney disease (CKD).
Original paper ↗Read more →Vitamin D receptor polymorphisms and bone health after kidney transplantation
We investigated the relationship between the polymorphisms of the vitamin D receptor ( VDR ) gene and bone diseases occurring after kidney transplantation.
Original paper ↗Read more →Original sources
NIH Office of Dietary Supplements – Vitamin D Fact Sheet
NIH Office of Dietary Supplements: Vitamin D Fact Sheet.
Publication details
NIH Office of Dietary Supplements: Vitamin D Fact Sheet
NCBI – Vitamin D physiology overview
NCBI: Vitamin D physiology overview.
Publication details
NCBI: Vitamin D physiology overview
MedlinePlus – Vitamin D
MedlinePlus: Vitamin D.
Publication details
MedlinePlus: Vitamin D